216 related articles for article (PubMed ID: 22268103)
1. Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide.
Salloum FN; Das A; Samidurai A; Hoke NN; Chau VQ; Ockaili RA; Stasch JP; Kukreja RC
Am J Physiol Heart Circ Physiol; 2012 Mar; 302(6):H1347-54. PubMed ID: 22268103
[TBL] [Abstract][Full Text] [Related]
2. NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size.
Bice JS; Keim Y; Stasch JP; Baxter GF
Cardiovasc Res; 2014 Feb; 101(2):220-8. PubMed ID: 24259501
[TBL] [Abstract][Full Text] [Related]
3. Preconditioning with soluble guanylate cyclase activation prevents postischemic inflammation and reduces nitrate tolerance in heme oxygenase-1 knockout mice.
Wang WZ; Jones AW; Wang M; Durante W; Korthuis RJ
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H521-32. PubMed ID: 23771693
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological activation of soluble guanylate cyclase protects the heart against ischemic injury.
Korkmaz S; Radovits T; Barnucz E; Hirschberg K; Neugebauer P; Loganathan S; Veres G; Páli S; Seidel B; Zöllner S; Karck M; Szabó G
Circulation; 2009 Aug; 120(8):677-86. PubMed ID: 19667237
[TBL] [Abstract][Full Text] [Related]
5. Pre-conditioning with the soluble guanylate cyclase activator Cinaciguat reduces ischaemia-reperfusion injury after cardiopulmonary bypass.
Radovits T; Korkmaz S; Miesel-Gröschel C; Seidel B; Stasch JP; Merkely B; Karck M; Szabó G
Eur J Cardiothorac Surg; 2011 Feb; 39(2):248-55. PubMed ID: 20591683
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide.
Salloum FN; Chau VQ; Hoke NN; Abbate A; Varma A; Ockaili RA; Toldo S; Kukreja RC
Circulation; 2009 Sep; 120(11 Suppl):S31-6. PubMed ID: 19752383
[TBL] [Abstract][Full Text] [Related]
7. Effects of soluble guanylate cyclase activation on heart transplantation in a rat model.
Loganathan S; Korkmaz-Icöz S; Radovits T; Li S; Mikles B; Barnucz E; Hirschberg K; Karck M; Szabó G
J Heart Lung Transplant; 2015 Oct; 34(10):1346-53. PubMed ID: 26210750
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotection by ischemic postconditioning and cyclic guanosine monophosphate-elevating agents involves cardiomyocyte nitric oxide-sensitive guanylyl cyclase.
Frankenreiter S; Groneberg D; Kuret A; Krieg T; Ruth P; Friebe A; Lukowski R
Cardiovasc Res; 2018 May; 114(6):822-829. PubMed ID: 29438488
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective PKG-independent NO signaling at reperfusion.
Cohen MV; Yang XM; Liu Y; Solenkova NV; Downey JM
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H2028-36. PubMed ID: 20852051
[TBL] [Abstract][Full Text] [Related]
10. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB
Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652
[TBL] [Abstract][Full Text] [Related]
11. Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension.
Chester M; Seedorf G; Tourneux P; Gien J; Tseng N; Grover T; Wright J; Stasch JP; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L755-64. PubMed ID: 21856817
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen sulfide mediates the cardioprotective effects of gene therapy with PKG-Iα.
Das A; Samidurai A; Hoke NN; Kukreja RC; Salloum FN
Basic Res Cardiol; 2015; 110(4):42. PubMed ID: 26036467
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective effects of PKG activation by soluble GC activator, BAY 60-2770, in ischemia-reperfusion-injured rat hearts.
Lee KH; Lee SR; Cho H; Woo JS; Kang JH; Jeong YM; Cheng XW; Kim WS; Kim W
PLoS One; 2017; 12(7):e0180207. PubMed ID: 28671970
[TBL] [Abstract][Full Text] [Related]
14. Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus.
Chester M; Tourneux P; Seedorf G; Grover TR; Gien J; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2009 Aug; 297(2):L318-25. PubMed ID: 19465519
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological stimulation of soluble guanylate cyclase modulates hypoxia-inducible factor-1alpha in rat heart.
Tsuruda T; Hatakeyama K; Masuyama H; Sekita Y; Imamura T; Asada Y; Kitamura K
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1274-80. PubMed ID: 19684186
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway.
Bibli SI; Andreadou I; Chatzianastasiou A; Tzimas C; Sanoudou D; Kranias E; Brouckaert P; Coletta C; Szabo C; Kremastinos DT; Iliodromitis EK; Papapetropoulos A
Cardiovasc Res; 2015 Jun; 106(3):432-42. PubMed ID: 25870184
[TBL] [Abstract][Full Text] [Related]
17. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
[TBL] [Abstract][Full Text] [Related]
18. Pressure-overload-induced subcellular relocalization/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation.
Tsai EJ; Liu Y; Koitabashi N; Bedja D; Danner T; Jasmin JF; Lisanti MP; Friebe A; Takimoto E; Kass DA
Circ Res; 2012 Jan; 110(2):295-303. PubMed ID: 22095726
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of cGMP signalling protects coronary endothelium against reperfusion-induced intercellular gap formation.
Kasseckert SA; Schäfer C; Kluger A; Gligorievski D; Tillmann J; Schlüter KD; Noll T; Sauer H; Piper HM; Abdallah Y
Cardiovasc Res; 2009 Jul; 83(2):381-7. PubMed ID: 19234300
[TBL] [Abstract][Full Text] [Related]
20. Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes.
Castro LR; Schittl J; Fischmeister R
Circ Res; 2010 Nov; 107(10):1232-40. PubMed ID: 20847310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
